Stock Price Quote

ARTILLEGENCE BIO-INNOVATIONS LTD.

NSE : NABSE : 512642ISIN CODE : INE576F01010Industry : Finance - InvestmentHouse : Private
BSE3.470 (0 %)
PREV CLOSE ( ) 3.47
OPEN PRICE ( ) 3.47
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3.72 (611)
VOLUME 289
TODAY'S LOW / HIGH ( )3.47 3.47
52 WK LOW / HIGH ( ) 3.473.47
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1983
Management Info
R C Singh - Chairman - Managing Director
Registered Office

Address 242 / 2 , Netaji Subhash Road,1st Floor,Flat No . 102,
Howrah,
West Bengal-711101

Phone

Email NA

Website  

Registrars Details
Adroit Corporate Services Pvt Ltd
17-20 Jaferbhoy Industrial Estate , 1st Floor,Makwana Road,Marol Naka,Mumbai
Listing : BSE, Kolkata

NEWS

18Aug Artillegence Bio Innovations fixes boo
Artillegence Bio Innovations has informed that the Register of Members &..
02Aug Artillegence Bio Innovations informs a
Artillegence Bio Innovations has informed about Standalone Financial Res..
09May Artillegence Bio Innovations informs a
Artillegence Bio Innovations has informed about Standalone Financial Res..
06May Artillegence Bio Innovations informs a
Artillegence Bio Innovations has informed about the Standalone Financial..
31Jan Artillegence Bio Innovations informs a
Artillegence Bio Innovations has informed about the Standalone Financial..

Financials

in Millions
QTR Jun 16 ANNUAL 16
Net Profit-0.060.03
Gross Profit -0.06 0.03
Operating Profit -0.060.03
Net Sales 0.050.53

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bombay Oxygen Invest (BSE)
peergroup  22098.10 (4.34%)
M.Cap ( in Cr)331.47
JSW Holdings (BSE)
peergroup  19380.45 (0.99%)
M.Cap ( in Cr)21511.57
Welspun Investments (BSE)
peergroup  809.00 (4.43%)
M.Cap ( in Cr)295.65
Nalwa Sons Invest. (BSE)
peergroup  5214.35 (0.64%)
M.Cap ( in Cr)2678.18
AK Capital Services (BSE)
peergroup  1071.80 (2.36%)
M.Cap ( in Cr)707.39

Shareholding Pattern

NON-INSTITUTION 99.97%
PROMOTERS 0.03%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Artillegence Bio-Innovations Ltd.

Artillegence Bio-Innovations Ltd. was incorporated in the year 1983. Its today's share price is 3.47. Its current market capitalisation stands at Rs 2.54 Cr. In the latest quarter, company has reported Gross Sales of Rs. 23.64 Cr and Total Income of Rs.23.76 Cr. The company's management includes R C Singh, Hiranand Jha, Naba Kumar Pal.

It is listed on the BSE with a BSE Code of 512642 , NSE with an NSE Symbol of and ISIN of INE576F01010. It's Registered office is at 242 / 2 , Netaji Subhash Road,1st Floor,Flat No . 102Howrah-711101, West Bengal. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Naushad & Co

1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.
1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.
Close X
OPEN

DEMAT ACCOUNT

AND START YOUR

INVESTMENT

JOURNEY WITH US
(You will receive a Call & SMS from our end)
Popup-Character

Disclaimer: NIRMAL BANG SECURITIES PVT LTD: Investment in Securities market are subject to market risks. Read all the related documents carefully before investing. Please read the Do’s and Don’ts prescribed by the Commodity Exchange before trading. We do not offer PMS Service for the Commodity segment. Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO. The securities quoted are exemplary and are not recommendatory. BSE (Member ID- 498): INB011072759, INF011072759, Exchange Registered Member in CDS; NSE MEMEBR ID- 09391): INB230939139, INF230939139, INE230939139; MSEI Member ID-1067): INB260939138, INF260939138, INE260939139: Single Registration No. INZ000202536, PMS Registration No: INP000002981; Research Analyst Registration No: INH000001766; NSDL/ CDSL: IN-DP-CDSL 37-99; Exchange Member ID: MCX - 56460, NCDEX - 1268, ICEX – 2073. Regd. Office: B-2, 301/302, 3rd Floor, Marathon Innova, Off Ganpatrao Kadam Marg, Lower Parel (W), Mumbai - 400013. Tel: 62738000/01; Fax: 62738010 | *NIRMAL BANG NIVESHALAYA PVT LTD: ARN – 111233, Mutual Fund Distributor. Mutual Fund Investments are subject to market risks. Please read the offer documents carefully before Investing.” Regd. Office: B - 201, Khandelwal House, Poddar Road, Near Poddar Park, Malad (East). Mumbai – 400097. | **NIRMAL BANG INSURANCE BROKING PVT LTD: IRDAI Registration No: 795 and Registration Code For the Insurance Broker: IRDAI/DB889/2021. Insurance is the subject matter of the solicitation. For more details on policy terms, conditions, exclusions, limitations, please refer/read policy brochure carefully before concluding sale.